Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.71 USD | -1.84% | +4.12% | -15.59% |
Apr. 30 | Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer | CI |
Mar. 08 | Akero Therapeutics Raises $367 Million From Share Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.59% | 1.39B | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- AKRO Stock
- News Akero Therapeutics, Inc.
- Morgan Stanley Cuts Price Target on Akero Therapeutics to $33 From $70, Maintains Overweight Rating